An unconventional role of BMP-smad1 signaling in DNA damage response: A mechanism for tumor suppression

Journal of Cellular Biochemistry

Volumn 115, Issue 3, 2014, Pages 450-456

  Liu, Huijuan ^a   Bao, Dandan ^a   Xia, Xuechun ^a   Chau, Jenny Fung Ling ^b   Li, Baojie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BONE MORPHOGENETIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; SMAD1 PROTEIN;

ARTICLE; BONE REMODELING; CANCER INHIBITION; DNA DAMAGE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SMAD1 PROTEIN;

EID: 84892690287     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24698     Document Type: Article

References (83)

1. Ahmed KM, Li JJ,. 2007. ATM-NF-kappaB connection as a target for tumor radiosensitization. Curr Cancer Drug Targets 7: 335-342.
2. Bartek J, Bartkova J, Lukas J,. 2007. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773-7779.
3. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J,. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
4. Beausejour CM, Campisi J,. 2006. Ageing: Balancing regeneration and cancer. Nature 443: 404-405.
5. Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE,. 2012. A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat Med 18: 227-234.
6. Bouquet F, Pal A, Pilones KA, Demaria S, Hann B, Akhurst RJ, Babb JS, Lonning SM, DeWyngaert JK, Formenti SC, Barcellos-Hoff MH,. 2011. TGFbeta1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res 17: 6754-6765.
7. Boutros R, Lobjois V, Ducommun B,. 2007. CDC25 phosphatases in cancer cells: Key players? Good targets ? Nat Rev Cancer 7: 495-507.
8. Canalis E, Economides AN, Gazzerro E,. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235.
9. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, Heery DM, Gaestel M, Eilers M, Willis AE, Bushell M,. 2010. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA 107: 5375-5380.
10. Chau JF, Jia D, Wang Z, Liu Z, Hu Y, Zhang X, Jia H, Lai KP, Leong WF, Au BJ, Mishina Y, Chen YG, Biondi C, Robertson E, Xie D, Liu H, He L, Wang X, Yu Q, Li B,. 2012. A crucial role for bone morphogenetic protein-Smad1 signalling in the DNA damage response. Nat Commun 3: 836.
11. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S,. 2003. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113: 301-314.
12. Drake JW, Charlesworth B, Charlesworth D, Crow JF,. 1998. Rates of spontaneous mutation. Genetics 148: 1667-1686.
13. Ghosh AK, Bhattacharyya S, Varga J,. 2004. The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells. J Biol Chem 279: 47455-47463.
14. Grosjean-Raillard J, Tailler M, Ades L, Perfettini JL, Fabre C, Braun T, De Botton S, Fenaux P, Kroemer G,. 2009. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 28: 1099-1109.
15. Hadian K, Krappmann D,. 2011. Signals from the nucleus: Activation of NF-kappaB by cytosolic ATM in the DNA damage response. Sci Signal 4: pe2.
16. Hanahan D, Weinberg RA, 2011. Hallmarks of cancer: The next generation. Cell 144: 646-74.
17. Harris SL, Levine AJ,. 2005. The p53 pathway: Positive and negative feedback loops. Oncogene 24: 2899-2908.
18. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C,. 2010. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol Cell 40: 63-74.
19. Hishiya A, Ito M, Aburatani H, Motoyama N, Ikeda K, Watanabe K,. 2005. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation. Bone 37: 497-503.
20. Hopker K, Hagmann H, Khurshid S, Chen S, Hasskamp P, Seeger-Nukpezah T, Schilberg K, Heukamp L, Lamkemeyer T, Sos ML, Thomas RK, Lowery D, Roels F, Fischer M, Liebau MC, Resch U, Kisner T, Rother F, Bartram MP, Muller RU, Fabretti F, Kurschat P, Schumacher B, Gaestel M, Medema RH, Yaffe MB, Schermer B, Reinhardt HC, Benzing T,. 2012. AATF/Che-1 acts as a phosphorylation- dependent molecular modulator to repress p53-driven apoptosis. EMBO J 31: 3961-3975.
21. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B,. 2001. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28: 184-187.
22. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S,. 2003. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576.
23. Ivanov A, Adams PD,. 2011. A damage limitation exercise. Nat Cell Biol 13: 193-195.
24. Jones DL, Rando TA,. 2011. Emerging models and paradigms for stem cell ageing. Nat Cell Biol 13: 506-512.
25. Jung M, Kondratyev A, Lee SA, Dimtchev A, Dritschilo A,. 1997. ATM gene product phosphorylates I kappa B-alpha. Cancer Res 57: 24-27.
26. Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V,. 2007. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Mol Cell Biol 27: 8228-8242.
27. Kastan MB, Lim DS,. 2000. The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1: 179-186.
28. Khanna KK, Jackson SP,. 2001. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 27: 247-254.
29. Kokabu S, Nojima J, Kanomata K, Ohte S, Yoda T, Fukuda T, Katagiri T,. 2010. Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res 25: 653-660.
30. Kua HY, Liu H, Leong WF, Li L, Jia D, Ma G, Hu Y, Wang X, Chau JF, Chen YG, Mishina Y, Boast S, Yeh J, Xia L, Chen GQ, He L, Goff SP, Li B,. 2012. c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression. Nat Cell Biol 14: 727-737.
31. Kumar S, Subramanian S,. 2002. Mutation rates in mammalian genomes. Proc Natl Acad Sci USA 99: 803-808.
32. Kunz BA, Ramachandran K, Vonarx EJ,. 1998. DNA sequence analysis of spontaneous mutagenesis in Saccharomyces cerevisiae. Genetics 148: 1491-1505.
33. Lane DP, Brown CJ, Verma C, Cheok CF,. 2011. New insights into p53 based therapy. Discov Med 12: 107-117.
34. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N,. 2005. ATM signaling and genomic stability in response to DNA damage. Mutat Res 569: 123-132.
35. Lempiainen H, Halazonetis TD,. 2009. Emerging common themes in regulation of PIKKs and PI3Ks. EMBO J 28: 3067-3073.
36. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, Kream BE, Stein GS, Lian JB, Jones SN,. 2006. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172: 909-921.
37. Li B,. 2005. c-Abl in oxidative stress, aging and cancer. Cell Cycle 4: 246-248.
38. Li B,. 2008. Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Endocr Metab Immune Disord Drug Targets 8: 208-219.
39. Li B, Boast S, de los Santos K, Schieren I, Quiroz M, Teitelbaum SL, Tondravi MM, Goff SP,. 2000. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 24: 304-308.
40. Lieber MR,. 2010. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 79: 181-211.
41. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen YG, Meng A, Feng XH,. 2006. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125: 915-928.
42. Lopez-Diaz FJ, Gascard P, Balakrishnan SK, Zhao J, Del Rincon SV, Spruck C, Tlsty TD, Emerson BM,. 2013. Coordinate transcriptional and translational repression of p53 by TGF-beta1 impairs the stress response. Mol Cell 50: 552-564.
43. Lukas C, Savic V, Bekker-Jensen S, Doil C, Neumann B, Pedersen RS, Grofte M, Chan KL, Hickson ID, Bartek J, Lukas J,. 2011. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol 13: 243-253.
44. Ma G, Li L, Hu Y, Chau JF, Au BJ, Jia D, Liu H, Yeh J, He L, Hao A, Li B,. 2012. Atypical Atm-p53 genetic interaction in osteogenesis is mediated by Smad1 signaling. J Mol Cell Biol 4: 118-120.
45. Maldonado M, Kapoor TM,. 2011. Constitutive Mad1 targeting to kinetochores uncouples checkpoint signalling from chromosome biorientation. Nat Cell Biol 13: 475-482.
46. McCool KW, Miyamoto S,. 2012. DNA damage-dependent NF-kappaB activation: NEMO turns nuclear signaling inside out. Immunol Rev 246: 311-326.
47. McGowan CH, Russell P,. 2004. The DNA damage response: Sensing and signaling. Curr Opin Cell Biol 16: 629-633.
48. Melino G,. 2011. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 18: 1487-1499.
49. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, Moll UM,. 2003. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577-590.
50. Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y, Tian C, He F, Zhang L,. 2010. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2. J Biol Chem 285: 22818-22830.
51. Osorio FG, Barcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo A, Freije JM, Lopez-Otin C,. 2012. Nuclear lamina defects cause ATM-dependent NF-kappaB activation and link accelerated aging to a systemic inflammatory response. Genes Dev 26: 2311-2324.
52. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM,. 2008. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28: 248-257.
53. Pendergast AM,. 2005. tress and death: Breaking up the c-Abl/14-3-3 complex in apoptosis. Nat Cell Biol 7: 213-214.
54. Pennacchio LA, Baroukh N, Rubin EM,. 2003. Human-mouse comparative genomics: Successes and failures to reveal functional regions of the human genome. Cold Spring Harb Symp Quant Biol 68: 303-309.
55. Rasheed N, Wang X, Niu QT, Yeh J, Li B,. 2006. Atm-deficient mice: An osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum Mol Genet 15: 1938-1948.
56. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W,. 2002. Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12: 162-169.
57. Reinhardt HC, Yaffe MB,. 2009. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 21: 245-255.
58. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB,. 2007. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11: 175-189.
59. Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, Carr SA, Yaffe MB,. 2010. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell 40: 34-49.
60. Riley T, Sontag E, Chen P, Levine A,. 2008. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
61. Rudolph J,. 2007. Cdc25 phosphatases: Structure, specificity, and mechanism. Biochemistry 46: 3595-3604.
62. Sakamoto K, Hikiba Y, Nakagawa H, Hirata Y, Hayakawa Y, Kinoshita H, Nakata W, Sakitani K, Takahashi R, Akanuma M, Kamata H, Maeda S,. 2012. Promotion of DNA repair by nuclear IKKbeta phosphorylation of ATM in response to genotoxic stimuli. Oncogene 32: 1854-1862.
63. Schmitt CA,. 2003. Senescence, apoptosis and therapy-Cutting the lifelines of cancer. Nat Rev Cancer 3: 286-295.
64. Stuart GR, Oda Y, de Boer JG, Glickman BW,. 2000. Mutation frequency and specificity with age in liver, bladder and brain of lacI transgenic mice. Genetics 154: 1291-1300.
65. Sun M, Guo X, Qian X, Wang H, Yang C, Brinkman KL, Serrano-Gonzalez M, Jope RS, Zhou B, Engler DA, Zhan M, Wong ST, Fu L, Xu B,. 2012. Activation of the ATM-Snail pathway promotes breast cancer metastasis. J Mol Cell Biol 4: 304-315.
66. Thorpe PH, Rothstein R,. 2012. Visualizing global effects of the DNA damage response. Nat Cell Biol 14: 900-901.
67. Varga AC, Wrana JL,. 2005. The disparate role of BMP in stem cell biology. Oncogene 24: 5713-5721.
68. Vogelstein B, Lane D, Levine AJ,. 2000. Surfing the p53 network. Nature 408: 307-310.
69. Volcic M, Karl S, Baumann B, Salles D, Daniel P, Fulda S, Wiesmuller L,. 2012. NF-kappaB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes. Nucleic Acids Res 40: 181-195.
70. Vousden KH, Lane DP,. 2007. p53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283.
71. Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, Li B,. 2006. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 172: 115-125.
72. Wang X, Zeng L, Wang J, Chau JF, Lai KP, Jia D, Poonepalli A, Hande MP, Liu H, He G, He L, Li B,. 2011. A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ 18: 5-15.
73. Wang M, Saha J, Hada M, Anderson JA, Pluth JM, O'Neill P, Cucinotta FA,. 2013. Novel Smad proteins localize to IR-induced double-strand breaks: Interplay between TGFbeta and ATM pathways. Nucleic Acids Res 41: 933-942.
74. Wilkinson DS, Ogden SK, Stratton SA, Piechan JL, Nguyen TT, Smulian GA, Barton MC,. 2005. A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol Cell Biol 25: 1200-1212.
75. Wong S, Witte ON,. 2004. The BCR-ABL story: Bench to bedside and back. Annu Rev Immunol 22: 247-306.
76. Wu J,. 2012. Genotoxic stresses and protein modifications. J Mol Cell Biol 4: 269.
77. Wu J,. 2013. DNA damage and tumorigenesis. J Mol Cell Biol 5: 155-156.
78. Xiao Z, Xue J, Sowin TJ, Zhang H,. 2006. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: Implications for cancer therapy. Mol Cancer Ther 5: 1935-1943.
79. Yang Y, Xia F, Hermance N, Mabb A, Simonson S, Morrissey S, Gandhi P, Munson M, Miyamoto S, Kelliher MA,. 2011. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage. Mol Cell Biol 31: 2774-8276.
80. Zambetti GP, Horwitz EM, Schipani E,. 2006. Skeletons in the p53 tumor suppressor closet: Genetic evidence that p53 blocks bone differentiation and development. J Cell Biol 172: 795-797.
81. Zannini L, Buscemi G, Kim JE, Fontanella E, Delia D,. 2012. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage. J Mol Cell Biol 4: 294-303.
82. Zhang J, Li L,. 2005. BMP signaling and stem cell regulation. Dev Biol 284: 1-11.
83. Zhang M, Li L, Wang Z, Liu H, Hou J, Zhang M, Hao A, Liu Y, He G, Shi Y, He L, Wang X, Wan Y, Li B,. 2013. A role for c-Abl in cell senescence and spontaneous immortalization. Age (Dordr) 35: 1251-1262.